2022 COLOGUARD CLASSIC AND TUCSON CONQUISTADORES
RAISE $723,672 FOR SOUTHERN ARIZONA CHARITIES
Tucson, Ariz. (June 20, 2022) – The Tucson Conquistadores announced today that $723,672.50 was raised for Southern Arizona charities from the 2022 Cologuard Classic golf tournament and Conquistador-led fundraising programs. The Conquistadores, the local civic organization and tournament management team oversees operations and sales for the PGA TOUR Champions event, have now raised more than $37.2 million for local charities since their inception in 1962, including more than $3,091,000 since the 2018 tournament, Cologuard’s first as title sponsor.
The 2022 Cologuard Classic was played February 25-27 at Omni Tucson National Resort and was won by Miguel Angel Jimenez with a winning score of 18-under par. The 2022 event welcomed back full spectators and hospitality suites after 2021 tournament attendance was limited to less than 200 per day and zero hospitality suites were permitted on course due to the pandemic.
In total, more than 80 local organizations will receive charitable funds as a result of the 2022 tournament, including First Tee-Tucson, El Rio Health Center Foundation, Pima County Health Department, DM 50, Boy Scouts of America, the Colon Cancer Coalition, Intermountain Centers, United Through Learning, Special Olympics of Arizona, and the Boys & Girls Clubs of Tucson. Charitable funds were raised through tournament ticket and hospitality suites sales, playing spots in the Caboose Cup Am-Am and Maestro Dobel Tequila Pro-Ams, the Military Appreciation Concert with Jake Owen and Diamond Rio, Drive To Know program, the tournament’s Birdies for Charity program, and the Celebrity Challenge which featured Annika Sorenstam, Larry Fitzgerald, Jake Owen and Eric Dickerson.
“We are very honored to host the Cologuard Classic and to play a part in supporting so many worthy causes throughout Southern Arizona,” said 2022 Cologuard Classic Tournament Chairman Josh Robinson. “The Tucson community always supports this event, and we are grateful to everyone that helped make this year a success!”
“We value and appreciate all that the Conquistadores and the Cologuard Classic do to help us bring awareness, education, hope and healing to the most vulnerable members of our Tucson community served by El Rio Health,” said Brenda Goldsmith, Executive Director of the El Rio Health Center Foundation. “The charitable support goes 100% to qualified patient care to cover the costs of colon cancer screening, consultations, diagnostics, and pathology for those in need.”
The Tucson Conquistadores, Inc. is a nonprofit organized for the purpose of supporting local youth and special needs amateur athletics primarily in Southern Arizona, with an emphasis on offering life enhancing opportunities to give back to the local community. The Conquistadores are comprised of up to 52 active business and professional members and a total membership of 223 who represent a cross-section of the Tucson community. Key beneficiaries of the Conquistadores' fundraising efforts include Southern Arizona youth athletic programs, First Tee-Tucson and colon cancer advocacy organizations. In addition to their involvement with professional golf, the group has also established the Tucson Conquistadores Foundation. Follow the Tucson Conquistadores online at www.tucsonconquistadores.com.
The Conquistadores review funding requests from organizations, clubs and individuals and determine contributions on a monthly basis. For more information on charitable funding and how to apply for a grant visit the Tucson Conquistadores’ website at www.tucsonconquistadores.com/funding-info-application.
The 2023 Cologuard Classic will take place at Omni Tucson National Resort February 27th through March 5 th . For more information on the Cologuard Classic, visitt www.CologuardClassic.com.
About PGA TOUR Champions
PGA TOUR Champions is a membership organization of professional golfers age 50 and older, including 34 members of the World Golf Hall of Fame. The Tour’s mission is to provide financial opportunities for its players, entertain and inspire its fans, deliver substantial value to its partners, create outlets for volunteers to give back and generate significant charitable and economic impact in tournament communities. Follow PGA TOUR Champions online at facebook.com/PGATOURChampions, on Twitter @ChampionsTour, on Instagram @pgatourchampions and on TikTok (pgatourchampions).
All events are televised in the United States, with most receiving complete coverage on GOLF Channel, the exclusive cable-television partner of PGA TOUR Champions. Tournament programming is available via 20-plus TV linear partners in 170-plus countries and territories, with 25 channels carrying long-form and/or highlights coverage, and 170-plus hours of live coverage distributed in 130-plus countries and territories. Programming is also available via the OTT platform GOLFTV powered by PGA TOUR in every market outside of the United States (240-plus countries and territories), excluding China, Korea and Russia, with live coverage distributed in 130-plus countries and territories.
The Cologuard test was approved by the FDA in August 2014, and results from Exact Sciences' prospective 90-site, point-in-time, 10,000-patient pivotal trial were published in the New England Journal of Medicine in March 2014. The Cologuard test is included in the American Cancer Society's (2018) colorectal cancer screening guidelines and the recommendations of the U.S. Preventive Services Task Force (2021) and National Comprehensive Cancer Network (2016). The Cologuard test is indicated to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use the Cologuard test if you have had precancer, have inflammatory bowel disease and certain hereditary syndromes, or have a personal or family history of colorectal cancer. The Cologuard test is not a replacement for colonoscopy in high-risk patients. The Cologuard test performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. The Cologuard test performance in repeat testing has not been evaluated
The Cologuard test result should be interpreted with caution. A positive test result does not confirm the
presence of cancer. Patients with a positive test result should be referred for diagnostic colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. Medicare and most major insurers cover the Cologuard test. For more information about the Cologuard test, visit www.cologuard.com. Rx only.
Tournament Media Contact: